INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Public ClinicalTrials.gov record NCT03547297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03547297
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Alnylam Pharmaceuticals
- Industry
- Enrollment
- 212 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2018
- Primary completion
- Jan 14, 2019
- Completion
- Jan 14, 2019
- Last update posted
- Jan 24, 2019
2018 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Pasadena | California | 91101 | — |
| Clinical Trial Site | Jacksonville | Florida | 32256 | — |
| Clinical Trial Site | Margate | Florida | 33063 | — |
| Clinical Trial Site | Ames | Iowa | 50010 | — |
| Clinical Trial Site | Las Vegas | Nevada | 89106 | — |
| Clinical Trial Site | Manhasset | New York | 11030 | — |
| Clinical Trial Site | Winston-Salem | North Carolina | 27103 | — |
| Clinical Trial Site | Pittsburgh | Pennsylvania | 15232 | — |
| Clinical Trial Site | Pottsville | Pennsylvania | 17901 | — |
| Clinical Trial Site | Knoxville | Tennessee | 37912 | — |
| Clinical Trial Site | Houston | Texas | 77025 | — |
| Clinical Trial Site | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03547297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2019 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03547297 live on ClinicalTrials.gov.